TG
TRV GP Portfolio holdings
AUM
$18.9M
This Quarter Return
-11.47%
1 Year Return
+541.67%
3 Year Return
+3,178.87%
5 Year Return
–
10 Year Return
–
AUM
$141M
AUM Growth
+$141M
(-36%)
Cap. Flow
-$65.4M
Cap. Flow
% of AUM
-46.37%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
CytomX Therapeutics
CTMX
|
$65.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rhythm Pharmaceuticals
RYTM
$6.85B
| $79.2M | 56.15% | 3,981,437 | – | – |
|
|
2
CytomX Therapeutics
CTMX
$336M
| $29M | 20.57% | 1,020,348 -2,300,000 | -69% | -$65.4M |
|
3
KALA BIO
KALA
$78.8M
| $26.2M | 18.56% | 1,654,425 | – | – |
|
4
Carisma Therapeutics
CARM
$8.98M
| $5.08M | 3.6% | 4,841,591 | – | – |
|
5
Larimar Therapeutics
LRMR
$310M
| $1.57M | 1.11% | 210,371 | – | – |
|